Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
January 31 2017 - 3:18PM
Edgar (US Regulatory)
|
|
OMB APPROVAL
|
OMB Number: 3235-0167
|
Expires: March 31, 2018
|
Estimated average burden hours per response ... 1.50
|
|
|
|
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO
FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 000-51206
Plandai Biotechnology, Inc.
(Exact name of registrant as specified in its
charter)
17
Hanover Square London England, W1S 1BN (917) 900-6829
(Address, including zip code, and telephone
number, including area code, of registrant's principal executive offices)
Common Stock
(Title of each class of securities covered by
this Form)
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)
|
☒
|
Rule 12g-4(a)(2)
|
☐
|
Rule 12h-3(b)(1)(i)
|
☐
|
Rule 12h-3(b)(2)(ii)
|
☐
|
Rule 15d-6
|
☐
|
Rule 15d-22(b)
|
☐
|
Approximate number of holders of record
as of the certification or notice date:
147
Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused
this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: January 31, 2017
|
By: /s/ Roger Baylis - Duffield
|
Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 and 15d-22 of the General Rules and Regulations under
the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall
be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The
name and title of the person signing the form shall be typed or printed under the signature.
SEC 2069 (08-11)
|
Persons who respond to the collection of information contained in this form are not required to
respond unless the form displays a currently valid OMB control number.
|
Plandai Biotechnology (PK) (USOTC:PLPL)
Historical Stock Chart
From Nov 2024 to Dec 2024
Plandai Biotechnology (PK) (USOTC:PLPL)
Historical Stock Chart
From Dec 2023 to Dec 2024
Real-Time news about Plandai Biotechnology Inc (PK) (OTCMarkets): 0 recent articles
More Plandai Biotechnology, Inc. News Articles
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Go Ad-Free
Subscribe to Ad free and enjoy an ad-free experience